Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies



Rating:

Share or cite this content

Citations should be made in the following way:
H. Shafiek (Alexandria, Egypt), A. Iglesias (Palma de Mallorca, Spain), C. Gomez (Palma de Mallorca, Spain), M. Mosteiro (Vigo, Spain), J. Ramos (Salamanca, Spain), A. Viña (Madrid, Spain), L. Perez De Llano (Lugo, Spain), . Torrego (Barcelona, Spain), I. Escribano (Madrid, Spain), C. Almonacid (Madrid, Spain), C. Melero (Madrid, Spain), C. Pinedo (Madrid, Spain), B. Cosio (Palma de Mallorca, Spain). Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma. 3736

Member's Comments

No comment yet.

Related content which might interest you: Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies? Source: Eur Respir J 2006; 27: 248-249 Year: 2006 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Nasal mucosa biopsy in severe astma patiens as a tool for the prediction of the inflammatory changes in lower airways Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Inverse relationship between eosinophils and neutrophils in bronchial biopsy from children with difficult asthma following systemic steroids Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003 Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005 Infectional factors influences on cytomorphological picture of bronchial biopsies at COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006 Infectional factors influences on cytomorphological picture of bronchial biopsies at COPD exacerbation Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Changes in lung function and airway eosinophilia after reduction of ICS treatment and recurrence of asthmatic symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 547s Year: 2003 Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes Source: Eur Respir J 2015; 46: 688-696 Year: 2015 Bronchial responsiveness, lung function and induced sputum eosinophilia in outgrown childhood asthma Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Sputum lymphocytes predict the severity of late asthmatic response in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004 Sputum mast cells associate with clinical and inflammatory features of asthma Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003